Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MT-ND4L Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5103953
Description
Antibody detects endogenous levels of total MT-ND4L.
NADH:ubiquinone oxidoreductase (complex I) is an extremely complicated multiprotein complex located in the inner mitochondrial membrane. Human complex I is important for energy metabolism because its main function is to transport electrons from NADH to ubiquinone, which is accompanied by translocation of protons from the mitochondrial matrix to the intermembrane space. Human complex I appears to consist of 41 subunits. A small number of complex I subunits are the products of mitochondrial genes (subunits 1-7), while the remainder are nuclear encoded and imported from the cytoplasm. NADH dehydrogenase subunit 4L (ND4L) is most likely a component of the hydrophobic protein fragment of Complex I. Mutations in the gene encodiing for ND4 are implicated in Leber hereditary optic neuropathy, a rare condition that can cause loss of central vision.
Specifications
| MT-ND4L | |
| Polyclonal | |
| Unconjugated | |
| MT-ND4L | |
| mitochondrially encoded NADH 4L dehydrogenase; MTND4L; mt-Nd4l; NADH dehydrogenase subunit 4L; NADH4L; NADH-ubiquinone oxidoreductase chain 4L; Nd4l | |
| Rabbit | |
| Affinity Chromatography | |
| RUO | |
| 17720, 4539 | |
| -20°C | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| P03901, P03903 | |
| MT-ND4L, ND4L | |
| A synthesized peptide derived from human MT-ND4L(Accession P03901), corresponding to amino acid residues M1-L49. | |
| 100 μL | |
| Primary | |
| Human, Mouse | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction